Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The story of Thanksgiving is one of struggle, learning, survival, and perseverance.
October means it’s time for another one of my notorious planned impromptu road trips.
It’s as though I’m taking another step on a tight rope with each successive PSA test.
First targeted therapy may prolong survival of men with advanced prostate cancer.
Tumors that turn off androgen receptor may have turned on new drug target.
One of the statements in the presentation that struck me was, “Just because you can see it, doesn’t mean you should treat it.”
I’ll be going through each article, gleaning whatever I think may be of value for the appointment, adding to my list of questions to ask.
I’m pretty sure the writing is on the wall that that salvage radiation is in my future.
Regularly consuming mushrooms reduced risk by up to 17% in a study involving Japanese men.
A $35 million gift from Marc and Lynne Benioff will accelerate research to transform prostate cancer treatment.
The team reasoned that if reducing DNA repair killed some cells, then a dramatically reducing DNA repair could kill even more.
My PSA took a considerable jump up to 0.16 ng/ml. I wasn’t expecting that.
September is Prostate Cancer Awareness Month
By combining the tools of pathology, computational modeling and genomics, the project hopes to discover and test therapeutic interventions.
A new study and meta-analysis found no long-term benefit from adding radiation therapy soon after surgery.
Two androgen receptor inhibitors improved survival by 33% in men with metastatic prostate cancer that responds to hormone therapy.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.